News

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...
A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Among them, WW International (WW), formerly known as WeightWatchers, hit a rough patch earlier this year, resulting in WW ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...